Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the effectiveness of the CADence system, a non-invasive device, in detecting greater than or equal to 50% coronary stenosis anywhere in the coronary tree.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AUM Cardiovascular, Inc.
NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more
NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease
NCT06779630 · Coronary Artery Disease
NCT05461729 · Coronary Artery Disease
NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more
Iowa Heart Center
Des Moines, Iowa
Mercy Hospital
Coon Rapids, Minnesota
Abbott/Minneapolis Heart Institute
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions